Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1998
06/24/1998CN1185433A Carotenoid preparation capable of mixing with liquid and oil
06/24/1998CN1185318A Anti-virus anti-infection compounded preparation for animals
06/24/1998CN1185317A 丁丙诺啡经皮吸收剂 Buprenorphine percutaneous absorption
06/24/1998CN1185316A Medicinal preparation containing saccharin zinc
06/24/1998CN1038840C Para-dinitrogen naphthalene derivative, its preparation method and medical use
06/24/1998CA2193940A1 Methods of elevating amounts of hyaluronan in the human body
06/24/1998CA2193921A1 Oral administration of effective amounts of forms of hyaluronic acid according to various standards
06/23/1998US5770772 4-formylamino-2,3,5-trimethyl-1-(2-methyl-2-propenyloxy) -benzene; arteriosclerosis, brain and cardiovascular disorders
06/23/1998US5770759 13,14-dihydro-15-keto-pgf's; vasopressors
06/23/1998US5770751 Meadowfoam sulfosuccinates
06/23/1998US5770749 Extracting creamy precipitate from pulping soap using solvent mixture of water, ketone and hydrocarbon, purifying
06/23/1998US5770740 Treating depression and obsessive compulsive disorders
06/23/1998US5770735 Neurokinin receptor antagonists
06/23/1998US5770734 N-substituted-2-aminoquinolines useful for treating hypofunction of the cholinergic system
06/23/1998US5770733 Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained
06/23/1998US5770732 Stable non-peptidal compounds which can inhibit the chemical activity of peptides and enzymes
06/23/1998US5770731 Improvements relating to prodrugs
06/23/1998US5770628 Eye disorders
06/23/1998US5770626 Tetrahydronaphtalene and indane compounds useful for reversing the photodamage in sun-exposed skin
06/23/1998US5770624 Inhibitors of tumor necrosis factor alpha and matrix degrading metalloproteinease activity
06/23/1998US5770623 Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
06/23/1998US5770618 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
06/23/1998US5770617 Terbenzimidazoles useful as antifungal agents
06/23/1998US5770616 Pharmaceutical composition for inhibiting the growth of cancers
06/23/1998US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with
06/23/1998US5770611 Indole derivatives as 5HT1 -like agonists
06/23/1998US5770610 Melatonin agonists for use in the treatment of benign prostatic hyperplasia (BPH)
06/23/1998US5770609 Administering tamoxifen derivatives to inhibit smooth muscle cell proliferation associated with vascular trauma from surgery or transplantation of organs or medical devices
06/23/1998US5770608 Heterocyclic derivatives
06/23/1998US5770607 Aqueous liquid composition for external use
06/23/1998US5770606 Administering apomorphine
06/23/1998US5770604 Aconitine compound and an antipyretic/analgesic/anti-inflammatory agent
06/23/1998US5770602 Quinoline or quinazoline derivatives, their production and use
06/23/1998US5770599 Quinazoline derivatives
06/23/1998US5770598 Antitumor agents; reacting with carbonyl diimidazole and amidoximes
06/23/1998US5770597 Antibiotic
06/23/1998US5770596 Pharmaceutical compositions based on mequitazine
06/23/1998US5770595 Oxime substituted therapeutic compounds
06/23/1998US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
06/23/1998US5770592 Vision defects
06/23/1998US5770589 Treatment of macular degeneration
06/23/1998US5770588 Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
06/23/1998US5770586 Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque
06/23/1998US5770584 Administering an alkyl lipid or alkyl lipid derivative viricides
06/23/1998US5770581 Gene transcription and ionizing radiation: methods and compositions
06/23/1998US5770579 Erythromycin compounds
06/23/1998US5770578 Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments
06/23/1998US5770575 Nipecotic acid derivatives as antithrombotic compounds
06/23/1998US5770574 Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory properties
06/23/1998US5770571 Method and agents for inhibiting protein aging
06/23/1998US5770455 Identifier tag which is a microchip that is pre-encoded or encodable with information that is related back to a detector when the tag is pulsed with electromagnetic radiation
06/23/1998US5770444 Growth differentiation factor-6
06/23/1998US5770430 Cellular injury response element and uses thereof
06/23/1998US5770401 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding
06/23/1998US5770386 Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
06/23/1998US5770366 Melanoma-inhibiting protein
06/23/1998US5770234 Particle induced amplification of immune response
06/23/1998US5770233 Container filled with infusion liquids and infusion preparation
06/23/1998US5770231 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles
06/23/1998US5770230 Method for preparing stabilized prostaglandin E1
06/23/1998US5770227 Progesterone replacement therapy
06/23/1998US5770226 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
06/23/1998US5770222 Therapeutic drug delivery systems
06/23/1998US5770219 Solid matrix system for transdermal drug delivery
06/23/1998US5770209 Acceleration of wound healing using connective tissue growth factor
06/23/1998US5770195 Antitumor
06/23/1998US5770184 Artificial fingernail method and composition
06/23/1998CA2222823A1 Composition of slap-130, a slp-76 associated protein and methods of use therefor
06/23/1998CA2176506C Substituted oxindoles
06/23/1998CA2158910C B3-adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia
06/23/1998CA2122271C Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
06/23/1998CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
06/23/1998CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
06/23/1998CA2086968C Quinazoline derivatives
06/23/1998CA2033531C Azaoxindole derivatives
06/23/1998CA2008739C Compositions and method for the treatment of disease
06/23/1998CA1339925C Affined heparinic oligosaccharides for cell growth factors
06/23/1998CA1339924C 11beta-phenyl-14betha steroids
06/20/1998CA2225273A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225267A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225202A1 Compositions for the treatment of chronic wounds
06/20/1998CA2224916A1 New polymorphous form of doxazosine mesylate (form 1)
06/20/1998CA2224884A1 New polymorphous form of doxazosine mesylate (form 11)
06/19/1998CA2225091A1 Piperazinophenyl-and piperazinophenyloxycarboxylic acid derivatives, and processes and intermediates for their preparation and pharmaceutical compositions comprising them
06/18/1998WO1998026074A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
06/18/1998WO1998026069A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026062A2 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
06/18/1998WO1998026047A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026043A1 Lactobacillus bifidus growth promoting composition and use thereof
06/18/1998WO1998026008A1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use
06/18/1998WO1998025964A1 Submucosa extracts
06/18/1998WO1998025949A1 Substituted 5-amino-1,3,4-thiadiazole-2-thiones
06/18/1998WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof
06/18/1998WO1998025942A1 Novel erythromycin derivatives, method for preparing them and their use as medicine
06/18/1998WO1998025929A1 Epothilone analogs
06/18/1998WO1998025925A1 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them
06/18/1998WO1998025924A1 8-azabicyclo[3.2.1]octane-, 8-azabicyclo[3.2.1]oct-6-ene-, 9-azabicyclo[3.3.1]nonane-, 9-aza-3-oxabicyclo[3.3.1]nonane- and 9-aza-3-thiabicyclo[3.3.1]nonane derivatives, their preparation and their use as insecticides
06/18/1998WO1998025920A1 3-pyridyl enantiomers and their use as analgesics
06/18/1998WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/18/1998WO1998025916A1 Novel benzopyran derivatives
1 ... 6639 6640 6641 6642 6643 6644 6645 6646 6647 6648 6649 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 ... 7860